Hikma Pharmaceuticals (Hikma Pharmaceuticals) Other Operating Expense : $-1 Mil (TTM As of Dec. 2023)

View and export this data going back to 2009. Start your Free Trial

What is Hikma Pharmaceuticals Other Operating Expense?

Hikma Pharmaceuticals's Other Operating Expense for the six months ended in Dec. 2023 was $-79 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 was $-1 Mil.

Hikma Pharmaceuticals's quarterly Other Operating Expense increased from Dec. 2022 ($-45 Mil) to Jun. 2023 ($78 Mil) but then declined from Jun. 2023 ($78 Mil) to Dec. 2023 ($-79 Mil).

Hikma Pharmaceuticals's annual Other Operating Expense declined from Dec. 2021 ($73 Mil) to Dec. 2022 ($-3 Mil) but then increased from Dec. 2022 ($-3 Mil) to Dec. 2023 ($-1 Mil).

Hikma Pharmaceuticals Other Operating Expense Historical Data

The historical data trend for Hikma Pharmaceuticals's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hikma Pharmaceuticals Other Operating Expense Chart

Hikma Pharmaceuticals Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Operating Expense

Get a 7-Day Free Trial

36.00

40.00

73.00

-3.00

-1.00

Hikma Pharmaceuticals Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Other Operating Expense	Get a 7-Day Free Trial															28.00	42.00	-45.00	78.00	-79.00

Hikma Pharmaceuticals Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-1 Mil.

Hikma Pharmaceuticals Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Hikma Pharmaceuticals's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Hikma Pharmaceuticals (Hikma Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hikma Pharmaceuticals PLC (OTCPK:HKMPF) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

HKMPY:USA HIKl:UK HIK:UK H5P:Germany

Address

1 New Burlington Place, London, GBR, W1S 2HR

Website

https://www.hikma.com

Hikma Pharmaceuticals PLC is engaged in the development, manufacture, and marketing of a broad range of generic, branded, and in-licensed pharmaceutical products. The firm operates in three segments: injectables, generics, and branded. The majority of the company's sales are based in the U.S. and to a lesser degree in the Middle East, North Africa, and Europe.